NICE refutes claims of pharma influence on CVD risk guidelines Media release 29 March 2014 Pages: 2 - 2
New project uses real-life patient data for drug development Media release 29 March 2014 Pages: 2 - 2
"Very early" ART initiation saves life years and $US billions Clinical study 29 March 2014 Pages: 4 - 4
Abiraterone acetate equal benefits but lower costs than enzalutamide Clinical study 29 March 2014 Pages: 4 - 4
How visual function is measured affects CEA results in wet AMD Clinical study 29 March 2014 Pages: 6 - 6
Fesoterodine cost effective in Spain, cost saving in Finland Clinical study 29 March 2014 Pages: 6 - 6
Pharmacists help GPs reduce errors, but is it cost effective? Clinical study 29 March 2014 Pages: 8 - 8
Scaling up ART cost effective for HIV control in South Africa Clinical study 29 March 2014 Pages: 9 - 9